Micronization Services
Our spiral jet mills have been designed to guarantee precise scalability. This enables the active ingredient to be followed from its first R&D phases through to commercial launch.
Micronisation of APIs, Excipients, Steroids, Cytotoxics, Cytostatics, HPAIs, and Antibiotics
Via Crocicchio Cortogna 6,
CH-6900 Lugano,
Switzerland
JETPHARMA (JP) and MICROCHEM (MCH) provide contract micronisation services to the pharmaceutical industry.
Founded in the 1960s by Alberto Martinoli, the companies have built a loyal and frequent customer base in the industry, developing their expertise with active pharmaceutical ingredients (API), inert substances, highly potent active ingredients (HPAI), cytotoxic and cytostatic drugs, steroids, and psychotropic substances.
They have achieved ever-increasing micronisation yields and ever-decreasing particle sizes, down to fractions of a micron.
In 2016, JP and MCH’s commercial and technical expertise were concentrated into new consultancy company MUnit. The group has developed a reputation for outstanding micronisation competence and excellent service levels.
JP and MCH provide a range of services for micronisation under containment to avoid cross-contamination and mix-ups, prevent the release of hazardous substances into the environment, and protect the active ingredients and operators.
JP’s Glove box and Half-Suite box isolators allow high-containment performance below 25ng/m³ (third party verified). Its flexible and dependable operations mean up to 120l of product can be handled and packaged quickly and efficiently.
The isolator can be used with different types and sizes of mill, handling a variety of activities including jet milling, sieving, pin milling, and particle size distribution (PSD) analysis.
JP and MCH offer excellent scalability, with the ability to maintain the same granulometric curve at ever-increasing production capacities.
Using a series of modular machines, the companies can micronize single gram quantities up to hundreds of kilograms, while retaining the same granulometry and performance.
JP and MCH have built an excellent reputation with regulatory authorities, including:
JP and MCH’s service range includes:
JP and MCH also offer a range of laboratory services for quality control purposes. These include:
To ensure exceptional levels of quality control, the companies also have an extensive range of advanced laboratory instruments and equipment. These include:
In addition, JP and MCH undertake a range of validation activities. These include:
To find out more or to make an enquiry, please contact MUnit, which operates as a single access point to all of JP and MCH services.
Our spiral jet mills have been designed to guarantee precise scalability. This enables the active ingredient to be followed from its first R&D phases through to commercial launch.
JP and MCH’s service range includes the micronisation of APIs, steroids, cytotoxics and cytostatics, high-potency active pharmaceutical ingredients (HPAI), and antibiotics (not Beta-lactams) with its spiral jet mills (MC JETMILL).
In response to increased demand for new high profile services from the global market, JETPHARMA addressed to customers like a close partner, as if it were a spin-off of the client company.
The real added value when managing the micronisation process of an API is the experience acquired in the field.
MUnit is exhibiting at the forthcoming Drug Delivery to the Lungs (DDL) conference at Edinburgh International Conference Centre.
MUNIT has announced it will be participating at the 5th Annual Controlled & Modified Drug Release Summit in Philadelphia, US.
MUNIT has announced that it will be participating at the 6th Annual World HPAPI congress in Basel, Switzerland.
MUnit, JETPHARMA and Microchem have announced they will be attending this year’s CPhI Woldwide and the co-located events ICSE, InnoPack, P-MEC and FDF.
MUNIT and its affiliates JETPHARMA and MICROCHEM are delighted to be a sponsor at the 8th American DDF Summit in San Francisco.
MUNIT is pleased to participate once again at the ChemOutsourcing event for pharmaceutical professionals.
MUnit has announced it will be showcasing its products at the Respiratory Drug Delivery (RDD) Conference at the JW Marriott in Tuscan, Arizona.
CPhI Japan is primarily a platform to establish new business relationships between European and Asian global pharmaceutical companies.
Munit has announced it will be participating as an exhibitor at the 4th Annual Formulation & Drug Delivery Congress in London, UK.
JP and MCH have announced they will be showcasing products at the 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Granada, Spain.
MUnit has announced it will be attending the 9th Global Drug Delivery & Formulation Summit in Berlin, Germany.
MUnit is glad to announce its participation in the forthcoming DCAT. The exhibition will take place in New York from 19 to 22 March 2018.
MUNIT has announced its commercial director Mr Schiavazzi will be attending PharmaChemOutsourcing at Long Branch, New Jersey.
Jetpharma will be attending the 2nd Annual Formulation & Drug Delivery Congress in London, UK.
Jetpharma will be attending the 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology from 4-7 April in Glasgow.
Jetpharma's services continue to grow and the company is proud to announce a new range of services through the installation of Sympatec Helos BR.
Jetpharma will attend CPhI Japan at the Big Sight Exhibition Center in Tokyo, Japan.
Jetpharma has successfully installed a new pin mill within the Cytotoxic compounds facility.
Via Sottobisio 42a/c
P.O. Box 234
CH-6828 Balerna
Switzerland
Via Turati 2
I-29017 Fiorenzuola d'Arda (PC)
Italy